WADHANE JITENDRA (SVP, Chief Accounting Officer) purchased 1.1% of their position (2.50K shares) of PYXIS ONCOLOGY, INC. on the open market
Open‑market purchase worth $4.7K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/27/2023ACC: 0001209191-23-050686
Officer· SVP, Chief Accounting Officer
Since Aug 2022
+2.50K
Net shares
Net buyer
$4.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.50K
Price / share
$1.87
Trade value
$4.67K
% of position
1.1%
9/27/2023
224.44K→226.94K
Total
Net shares
+2.50K
Net value
$4.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/27/2023 | P · Purchase | +2.50K | $1.87 | $4.67K | 1.1% | 224.44K | 226.94K |
| Total | +2.50K | $4.67K | ||||||
Derivative Transactions0
No derivative transactions reported